source_file,language,status,last_updated,title
Antidepressants/Bupropion/01 -   - In a nutshell -  Bupropion.md,de,translated,2025-01-16,In a nutshell
Antidepressants/Bupropion/01 -   - In a nutshell -  Bupropion.md,es,translated,2025-01-16,In a nutshell
Antidepressants/Bupropion/01 -   - In a nutshell -  Bupropion.md,fr,translated,2025-01-16,In a nutshell
Antidepressants/Bupropion/01 -   - In a nutshell -  Bupropion.md,it,translated,2025-01-16,In a nutshell
Antidepressants/Bupropion/01 -   - In a nutshell -  Bupropion.md,pt,translated,2025-01-16,In a nutshell
Antidepressants/Bupropion/02 -  - Pharmacodynamics - Bupropion.md,de,translated,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Bupropion/02 -  - Pharmacodynamics - Bupropion.md,es,translated,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Bupropion/02 -  - Pharmacodynamics - Bupropion.md,fr,translated,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Bupropion/02 -  - Pharmacodynamics - Bupropion.md,it,translated,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Bupropion/02 -  - Pharmacodynamics - Bupropion.md,pt,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Bupropion/03 -   - Pharmacokinetics - Bupropion.md,de,pending,2025-01-16,Pharmacokinetics
Antidepressants/Bupropion/03 -   - Pharmacokinetics - Bupropion.md,es,pending,2025-01-16,Pharmacokinetics
Antidepressants/Bupropion/03 -   - Pharmacokinetics - Bupropion.md,fr,pending,2025-01-16,Pharmacokinetics
Antidepressants/Bupropion/03 -   - Pharmacokinetics - Bupropion.md,it,pending,2025-01-16,Pharmacokinetics
Antidepressants/Bupropion/03 -   - Pharmacokinetics - Bupropion.md,pt,pending,2025-01-16,Pharmacokinetics
Antidepressants/Bupropion/04 -   - Dosage forms and strengths - Bupropion.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Bupropion/04 -   - Dosage forms and strengths - Bupropion.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Bupropion/04 -   - Dosage forms and strengths - Bupropion.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Bupropion/04 -   - Dosage forms and strengths - Bupropion.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Bupropion/04 -   - Dosage forms and strengths - Bupropion.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Bupropion/05 -  - Indications - Bupropion.md,de,pending,2025-01-16,Indications
Antidepressants/Bupropion/05 -  - Indications - Bupropion.md,es,pending,2025-01-16,Indications
Antidepressants/Bupropion/05 -  - Indications - Bupropion.md,fr,pending,2025-01-16,Indications
Antidepressants/Bupropion/05 -  - Indications - Bupropion.md,it,pending,2025-01-16,Indications
Antidepressants/Bupropion/05 -  - Indications - Bupropion.md,pt,pending,2025-01-16,Indications
Antidepressants/Bupropion/06 - お - Side effects - Bupropion.md,de,pending,2025-01-16,Side Effects
Antidepressants/Bupropion/06 - お - Side effects - Bupropion.md,es,pending,2025-01-16,Side Effects
Antidepressants/Bupropion/06 - お - Side effects - Bupropion.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Bupropion/06 - お - Side effects - Bupropion.md,it,pending,2025-01-16,Side Effects
Antidepressants/Bupropion/06 - お - Side effects - Bupropion.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Bupropion/07 -  - Use in special populations - Bupropion.md,de,pending,2025-01-16,Use in special populations
Antidepressants/Bupropion/07 -  - Use in special populations - Bupropion.md,es,pending,2025-01-16,Use in special populations
Antidepressants/Bupropion/07 -  - Use in special populations - Bupropion.md,fr,pending,2025-01-16,Use in special populations
Antidepressants/Bupropion/07 -  - Use in special populations - Bupropion.md,it,pending,2025-01-16,Use in special populations
Antidepressants/Bupropion/07 -  - Use in special populations - Bupropion.md,pt,pending,2025-01-16,Use in special populations
Antidepressants/Bupropion/08 -  Brand names - Bupropion.md,de,pending,2025-01-16,Brand names
Antidepressants/Bupropion/08 -  Brand names - Bupropion.md,es,pending,2025-01-16,Brand names
Antidepressants/Bupropion/08 -  Brand names - Bupropion.md,fr,pending,2025-01-16,Brand names
Antidepressants/Bupropion/08 -  Brand names - Bupropion.md,it,pending,2025-01-16,Brand names
Antidepressants/Bupropion/08 -  Brand names - Bupropion.md,pt,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/01 -    - In a nutshell -  Desvenlafaxine.md,de,pending,2025-01-16,In a nutshell
Antidepressants/Desvenlafaxine/01 -    - In a nutshell -  Desvenlafaxine.md,es,pending,2025-01-16,In a nutshell
Antidepressants/Desvenlafaxine/01 -    - In a nutshell -  Desvenlafaxine.md,fr,pending,2025-01-16,In a nutshell
Antidepressants/Desvenlafaxine/01 -    - In a nutshell -  Desvenlafaxine.md,it,pending,2025-01-16,In a nutshell
Antidepressants/Desvenlafaxine/01 -    - In a nutshell -  Desvenlafaxine.md,pt,pending,2025-01-16,In a nutshell
Antidepressants/Desvenlafaxine/02 -  - Pharmacodynamics - Desvenlafaxine.md,de,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Desvenlafaxine/02 -  - Pharmacodynamics - Desvenlafaxine.md,es,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Desvenlafaxine/02 -  - Pharmacodynamics - Desvenlafaxine.md,fr,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Desvenlafaxine/02 -  - Pharmacodynamics - Desvenlafaxine.md,it,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Desvenlafaxine/02 -  - Pharmacodynamics - Desvenlafaxine.md,pt,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Desvenlafaxine/03 -   - Pharmacokinetics - Desvenlafaxine.md,de,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/03 -   - Pharmacokinetics - Desvenlafaxine.md,es,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/03 -   - Pharmacokinetics - Desvenlafaxine.md,fr,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/03 -   - Pharmacokinetics - Desvenlafaxine.md,it,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/03 -   - Pharmacokinetics - Desvenlafaxine.md,pt,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/04 -   - Dosage forms and strengths - Desvenlafaxine.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Desvenlafaxine/04 -   - Dosage forms and strengths - Desvenlafaxine.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Desvenlafaxine/04 -   - Dosage forms and strengths - Desvenlafaxine.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Desvenlafaxine/04 -   - Dosage forms and strengths - Desvenlafaxine.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Desvenlafaxine/04 -   - Dosage forms and strengths - Desvenlafaxine.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Desvenlafaxine/05 - Desvenlafaxine - Indications.md,de,pending,2025-01-16,Indications
Antidepressants/Desvenlafaxine/05 - Desvenlafaxine - Indications.md,es,pending,2025-01-16,Indications
Antidepressants/Desvenlafaxine/05 - Desvenlafaxine - Indications.md,fr,pending,2025-01-16,Indications
Antidepressants/Desvenlafaxine/05 - Desvenlafaxine - Indications.md,it,pending,2025-01-16,Indications
Antidepressants/Desvenlafaxine/05 - Desvenlafaxine - Indications.md,pt,pending,2025-01-16,Indications
Antidepressants/Desvenlafaxine/06 - お - Side effects - Desvenlafaxine.md,de,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/06 - お - Side effects - Desvenlafaxine.md,es,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/06 - お - Side effects - Desvenlafaxine.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/06 - お - Side effects - Desvenlafaxine.md,it,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/06 - お - Side effects - Desvenlafaxine.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/07 -  - Use in special populations - Desvenlafaxine.md,de,pending,2025-01-16,Use in special populations
Antidepressants/Desvenlafaxine/07 -  - Use in special populations - Desvenlafaxine.md,es,pending,2025-01-16,Use in special populations
Antidepressants/Desvenlafaxine/07 -  - Use in special populations - Desvenlafaxine.md,fr,pending,2025-01-16,Use in special populations
Antidepressants/Desvenlafaxine/07 -  - Use in special populations - Desvenlafaxine.md,it,pending,2025-01-16,Use in special populations
Antidepressants/Desvenlafaxine/07 -  - Use in special populations - Desvenlafaxine.md,pt,pending,2025-01-16,Use in special populations
Antidepressants/Desvenlafaxine/08 -  Brand names - Desvenlafaxine.md,de,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/08 -  Brand names - Desvenlafaxine.md,es,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/08 -  Brand names - Desvenlafaxine.md,fr,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/08 -  Brand names - Desvenlafaxine.md,it,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/08 -  Brand names - Desvenlafaxine.md,pt,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/Commented/BG005.md,de,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/Commented/BG005.md,es,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/Commented/BG005.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/Commented/BG005.md,it,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/Commented/BG005.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 02 -  - Pharmacodynamics - Desvenlafaxine.md,de,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 02 -  - Pharmacodynamics - Desvenlafaxine.md,es,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 02 -  - Pharmacodynamics - Desvenlafaxine.md,fr,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 02 -  - Pharmacodynamics - Desvenlafaxine.md,it,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 02 -  - Pharmacodynamics - Desvenlafaxine.md,pt,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 03 -   - Pharmacokinetics - Desvenlafaxine.md,de,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 03 -   - Pharmacokinetics - Desvenlafaxine.md,es,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 03 -   - Pharmacokinetics - Desvenlafaxine.md,fr,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 03 -   - Pharmacokinetics - Desvenlafaxine.md,it,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 03 -   - Pharmacokinetics - Desvenlafaxine.md,pt,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 04 -   - Dosage forms and strengths - Desvenlafaxine.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 04 -   - Dosage forms and strengths - Desvenlafaxine.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 04 -   - Dosage forms and strengths - Desvenlafaxine.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 04 -   - Dosage forms and strengths - Desvenlafaxine.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 04 -   - Dosage forms and strengths - Desvenlafaxine.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 05-  - Indications - Desvenlafaxine.md,de,pending,2025-01-16,Indications
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 05-  - Indications - Desvenlafaxine.md,es,pending,2025-01-16,Indications
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 05-  - Indications - Desvenlafaxine.md,fr,pending,2025-01-16,Indications
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 05-  - Indications - Desvenlafaxine.md,it,pending,2025-01-16,Indications
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 05-  - Indications - Desvenlafaxine.md,pt,pending,2025-01-16,Indications
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 06 - お -Side effects - Desvenlafaxine.md,de,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 06 - お -Side effects - Desvenlafaxine.md,es,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 06 - お -Side effects - Desvenlafaxine.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 06 - お -Side effects - Desvenlafaxine.md,it,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 06 - お -Side effects - Desvenlafaxine.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 07 -  - Use in special populations - Desvenlafaxine.md,de,pending,2025-01-16,Use in special populations
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 07 -  - Use in special populations - Desvenlafaxine.md,es,pending,2025-01-16,Use in special populations
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 07 -  - Use in special populations - Desvenlafaxine.md,fr,pending,2025-01-16,Use in special populations
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 07 -  - Use in special populations - Desvenlafaxine.md,it,pending,2025-01-16,Use in special populations
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 07 -  - Use in special populations - Desvenlafaxine.md,pt,pending,2025-01-16,Use in special populations
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 08 -  Brand names - Desvenlafaxine.md,de,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 08 -  Brand names - Desvenlafaxine.md,es,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 08 -  Brand names - Desvenlafaxine.md,fr,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 08 -  Brand names - Desvenlafaxine.md,it,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/Commented/REV & MERGED - 08 -  Brand names - Desvenlafaxine.md,pt,pending,2025-01-16,Brand names
Antidepressants/Desvenlafaxine/Commented/REV & MERGED 01 -   - In a nutshell -  Desvenlafaxine.md,de,pending,2025-01-16,In a nutshell
Antidepressants/Desvenlafaxine/Commented/REV & MERGED 01 -   - In a nutshell -  Desvenlafaxine.md,es,pending,2025-01-16,In a nutshell
Antidepressants/Desvenlafaxine/Commented/REV & MERGED 01 -   - In a nutshell -  Desvenlafaxine.md,fr,pending,2025-01-16,In a nutshell
Antidepressants/Desvenlafaxine/Commented/REV & MERGED 01 -   - In a nutshell -  Desvenlafaxine.md,it,pending,2025-01-16,In a nutshell
Antidepressants/Desvenlafaxine/Commented/REV & MERGED 01 -   - In a nutshell -  Desvenlafaxine.md,pt,pending,2025-01-16,In a nutshell
Antidepressants/Desvenlafaxine/Desvenlafaxine.md,de,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/Desvenlafaxine.md,es,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/Desvenlafaxine.md,fr,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/Desvenlafaxine.md,it,pending,2025-01-16,Pharmacokinetics
Antidepressants/Desvenlafaxine/Desvenlafaxine.md,pt,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/01 -   - In a nutshell -  Duloxetine.md,de,pending,2025-01-16,In a nutshell
Antidepressants/Duloxetine/01 -   - In a nutshell -  Duloxetine.md,es,pending,2025-01-16,In a nutshell
Antidepressants/Duloxetine/01 -   - In a nutshell -  Duloxetine.md,fr,pending,2025-01-16,In a nutshell
Antidepressants/Duloxetine/01 -   - In a nutshell -  Duloxetine.md,it,pending,2025-01-16,In a nutshell
Antidepressants/Duloxetine/01 -   - In a nutshell -  Duloxetine.md,pt,pending,2025-01-16,In a nutshell
Antidepressants/Duloxetine/02 -  - Pharmacodynamics - Duloxetine.md,de,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Duloxetine/02 -  - Pharmacodynamics - Duloxetine.md,es,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Duloxetine/02 -  - Pharmacodynamics - Duloxetine.md,fr,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Duloxetine/02 -  - Pharmacodynamics - Duloxetine.md,it,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Duloxetine/02 -  - Pharmacodynamics - Duloxetine.md,pt,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Duloxetine/03 -   - Pharmacokinetics - Duloxetine.md,de,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/03 -   - Pharmacokinetics - Duloxetine.md,es,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/03 -   - Pharmacokinetics - Duloxetine.md,fr,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/03 -   - Pharmacokinetics - Duloxetine.md,it,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/03 -   - Pharmacokinetics - Duloxetine.md,pt,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/04 -   - Dosage forms and strengths - Duloxetine.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/04 -   - Dosage forms and strengths - Duloxetine.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/04 -   - Dosage forms and strengths - Duloxetine.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/04 -   - Dosage forms and strengths - Duloxetine.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/04 -   - Dosage forms and strengths - Duloxetine.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/05 -  - Indications - Duloxetine.md,de,pending,2025-01-16,Indications
Antidepressants/Duloxetine/05 -  - Indications - Duloxetine.md,es,pending,2025-01-16,Indications
Antidepressants/Duloxetine/05 -  - Indications - Duloxetine.md,fr,pending,2025-01-16,Indications
Antidepressants/Duloxetine/05 -  - Indications - Duloxetine.md,it,pending,2025-01-16,Indications
Antidepressants/Duloxetine/05 -  - Indications - Duloxetine.md,pt,pending,2025-01-16,Indications
Antidepressants/Duloxetine/06 - お - Side effects - Duloxetine.md,de,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/06 - お - Side effects - Duloxetine.md,es,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/06 - お - Side effects - Duloxetine.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/06 - お - Side effects - Duloxetine.md,it,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/06 - お - Side effects - Duloxetine.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/07 -  - Use in special populations - Duloxetine.md,de,pending,2025-01-16,Use in special populations
Antidepressants/Duloxetine/07 -  - Use in special populations - Duloxetine.md,es,pending,2025-01-16,Use in special populations
Antidepressants/Duloxetine/07 -  - Use in special populations - Duloxetine.md,fr,pending,2025-01-16,Use in special populations
Antidepressants/Duloxetine/07 -  - Use in special populations - Duloxetine.md,it,pending,2025-01-16,Use in special populations
Antidepressants/Duloxetine/07 -  - Use in special populations - Duloxetine.md,pt,pending,2025-01-16,Use in special populations
Antidepressants/Duloxetine/08 -  Brand names - Duloxetine.md,de,pending,2025-01-16,Brand names
Antidepressants/Duloxetine/08 -  Brand names - Duloxetine.md,es,pending,2025-01-16,Brand names
Antidepressants/Duloxetine/08 -  Brand names - Duloxetine.md,fr,pending,2025-01-16,Brand names
Antidepressants/Duloxetine/08 -  Brand names - Duloxetine.md,it,pending,2025-01-16,Brand names
Antidepressants/Duloxetine/08 -  Brand names - Duloxetine.md,pt,pending,2025-01-16,Brand names
Antidepressants/Duloxetine/Commented/BG006.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/Commented/BG006.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/Commented/BG006.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/Commented/BG006.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/Commented/BG006.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/Commented/Commented.md,de,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/Commented/Commented.md,es,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/Commented/Commented.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/Commented/Commented.md,it,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/Commented/Commented.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/Commented/REV - 01 -   - In a nutshell -  Duloxetine.md,de,pending,2025-01-16,In a nutshell
Antidepressants/Duloxetine/Commented/REV - 01 -   - In a nutshell -  Duloxetine.md,es,pending,2025-01-16,In a nutshell
Antidepressants/Duloxetine/Commented/REV - 01 -   - In a nutshell -  Duloxetine.md,fr,pending,2025-01-16,In a nutshell
Antidepressants/Duloxetine/Commented/REV - 01 -   - In a nutshell -  Duloxetine.md,it,pending,2025-01-16,In a nutshell
Antidepressants/Duloxetine/Commented/REV - 01 -   - In a nutshell -  Duloxetine.md,pt,pending,2025-01-16,In a nutshell
Antidepressants/Duloxetine/Commented/REV - 02 -  - Pharmacodynamics - Duloxetine.md,de,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Duloxetine/Commented/REV - 02 -  - Pharmacodynamics - Duloxetine.md,es,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Duloxetine/Commented/REV - 02 -  - Pharmacodynamics - Duloxetine.md,fr,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Duloxetine/Commented/REV - 02 -  - Pharmacodynamics - Duloxetine.md,it,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Duloxetine/Commented/REV - 02 -  - Pharmacodynamics - Duloxetine.md,pt,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Duloxetine/Commented/REV - 03 -   - Pharmacokinetics - Duloxetine.md,de,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/Commented/REV - 03 -   - Pharmacokinetics - Duloxetine.md,es,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/Commented/REV - 03 -   - Pharmacokinetics - Duloxetine.md,fr,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/Commented/REV - 03 -   - Pharmacokinetics - Duloxetine.md,it,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/Commented/REV - 03 -   - Pharmacokinetics - Duloxetine.md,pt,pending,2025-01-16,Pharmacokinetics
Antidepressants/Duloxetine/Commented/REV - 04 -   - Dosage forms and strengths - Duloxetine.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/Commented/REV - 04 -   - Dosage forms and strengths - Duloxetine.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/Commented/REV - 04 -   - Dosage forms and strengths - Duloxetine.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/Commented/REV - 04 -   - Dosage forms and strengths - Duloxetine.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/Commented/REV - 04 -   - Dosage forms and strengths - Duloxetine.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Duloxetine/Commented/REV - 05 -  - Indications - Duloxetine.md,de,pending,2025-01-16,Indications
Antidepressants/Duloxetine/Commented/REV - 05 -  - Indications - Duloxetine.md,es,pending,2025-01-16,Indications
Antidepressants/Duloxetine/Commented/REV - 05 -  - Indications - Duloxetine.md,fr,pending,2025-01-16,Indications
Antidepressants/Duloxetine/Commented/REV - 05 -  - Indications - Duloxetine.md,it,pending,2025-01-16,Indications
Antidepressants/Duloxetine/Commented/REV - 05 -  - Indications - Duloxetine.md,pt,pending,2025-01-16,Indications
Antidepressants/Duloxetine/Commented/REV - 06 - お - Side effects - Duloxetine.md,de,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/Commented/REV - 06 - お - Side effects - Duloxetine.md,es,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/Commented/REV - 06 - お - Side effects - Duloxetine.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/Commented/REV - 06 - お - Side effects - Duloxetine.md,it,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/Commented/REV - 06 - お - Side effects - Duloxetine.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Duloxetine/Commented/REV - 07 -  - Use in special populations - Duloxetine.md,de,pending,2025-01-16,Use in special populations
Antidepressants/Duloxetine/Commented/REV - 07 -  - Use in special populations - Duloxetine.md,es,pending,2025-01-16,Use in special populations
Antidepressants/Duloxetine/Commented/REV - 07 -  - Use in special populations - Duloxetine.md,fr,pending,2025-01-16,Use in special populations
Antidepressants/Duloxetine/Commented/REV - 07 -  - Use in special populations - Duloxetine.md,it,pending,2025-01-16,Use in special populations
Antidepressants/Duloxetine/Commented/REV - 07 -  - Use in special populations - Duloxetine.md,pt,pending,2025-01-16,Use in special populations
Antidepressants/Duloxetine/Commented/REV - 08 -  Brand names - Duloxetine.md,de,pending,2025-01-16,Brand names
Antidepressants/Duloxetine/Commented/REV - 08 -  Brand names - Duloxetine.md,es,pending,2025-01-16,Brand names
Antidepressants/Duloxetine/Commented/REV - 08 -  Brand names - Duloxetine.md,fr,pending,2025-01-16,Brand names
Antidepressants/Duloxetine/Commented/REV - 08 -  Brand names - Duloxetine.md,it,pending,2025-01-16,Brand names
Antidepressants/Duloxetine/Commented/REV - 08 -  Brand names - Duloxetine.md,pt,pending,2025-01-16,Brand names
Antidepressants/Duloxetine/Commented/Reuni贸n cierre Duloxetina.md,de,pending,2025-01-16,
Antidepressants/Duloxetine/Commented/Reuni贸n cierre Duloxetina.md,es,pending,2025-01-16,
Antidepressants/Duloxetine/Commented/Reuni贸n cierre Duloxetina.md,fr,pending,2025-01-16,
Antidepressants/Duloxetine/Commented/Reuni贸n cierre Duloxetina.md,it,pending,2025-01-16,
Antidepressants/Duloxetine/Commented/Reuni贸n cierre Duloxetina.md,pt,pending,2025-01-16,
Antidepressants/Duloxetine/Revised bleeding recommendations.md,de,pending,2025-01-16,
Antidepressants/Duloxetine/Revised bleeding recommendations.md,es,pending,2025-01-16,
Antidepressants/Duloxetine/Revised bleeding recommendations.md,fr,pending,2025-01-16,
Antidepressants/Duloxetine/Revised bleeding recommendations.md,it,pending,2025-01-16,
Antidepressants/Duloxetine/Revised bleeding recommendations.md,pt,pending,2025-01-16,
Antidepressants/Levomilnacipran/01 -   - In a nutshell -  Levomilnacipran.md,de,pending,2025-01-16,In a nutshell
Antidepressants/Levomilnacipran/01 -   - In a nutshell -  Levomilnacipran.md,es,pending,2025-01-16,In a nutshell
Antidepressants/Levomilnacipran/01 -   - In a nutshell -  Levomilnacipran.md,fr,pending,2025-01-16,In a nutshell
Antidepressants/Levomilnacipran/01 -   - In a nutshell -  Levomilnacipran.md,it,pending,2025-01-16,In a nutshell
Antidepressants/Levomilnacipran/01 -   - In a nutshell -  Levomilnacipran.md,pt,pending,2025-01-16,In a nutshell
Antidepressants/Levomilnacipran/02 -  - Pharmacodynamics - Levomilnacipran.md,de,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Levomilnacipran/02 -  - Pharmacodynamics - Levomilnacipran.md,es,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Levomilnacipran/02 -  - Pharmacodynamics - Levomilnacipran.md,fr,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Levomilnacipran/02 -  - Pharmacodynamics - Levomilnacipran.md,it,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Levomilnacipran/02 -  - Pharmacodynamics - Levomilnacipran.md,pt,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Levomilnacipran/03 -   - Pharmacokinetics - Levomilnacipran.md,de,pending,2025-01-16,Pharmacokinetics
Antidepressants/Levomilnacipran/03 -   - Pharmacokinetics - Levomilnacipran.md,es,pending,2025-01-16,Pharmacokinetics
Antidepressants/Levomilnacipran/03 -   - Pharmacokinetics - Levomilnacipran.md,fr,pending,2025-01-16,Pharmacokinetics
Antidepressants/Levomilnacipran/03 -   - Pharmacokinetics - Levomilnacipran.md,it,pending,2025-01-16,Pharmacokinetics
Antidepressants/Levomilnacipran/03 -   - Pharmacokinetics - Levomilnacipran.md,pt,pending,2025-01-16,Pharmacokinetics
Antidepressants/Levomilnacipran/04 -   - Dosage forms and strengths - Levomilnacipran.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Levomilnacipran/04 -   - Dosage forms and strengths - Levomilnacipran.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Levomilnacipran/04 -   - Dosage forms and strengths - Levomilnacipran.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Levomilnacipran/04 -   - Dosage forms and strengths - Levomilnacipran.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Levomilnacipran/04 -   - Dosage forms and strengths - Levomilnacipran.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Levomilnacipran/05 -  - Indications - Levomilnacipran.md,de,pending,2025-01-16,
Antidepressants/Levomilnacipran/05 -  - Indications - Levomilnacipran.md,es,pending,2025-01-16,
Antidepressants/Levomilnacipran/05 -  - Indications - Levomilnacipran.md,fr,pending,2025-01-16,
Antidepressants/Levomilnacipran/05 -  - Indications - Levomilnacipran.md,it,pending,2025-01-16,
Antidepressants/Levomilnacipran/05 -  - Indications - Levomilnacipran.md,pt,pending,2025-01-16,
Antidepressants/Levomilnacipran/06 - お - Side effects - Levomilnacipran.md,de,pending,2025-01-16,Side Effects
Antidepressants/Levomilnacipran/06 - お - Side effects - Levomilnacipran.md,es,pending,2025-01-16,Side Effects
Antidepressants/Levomilnacipran/06 - お - Side effects - Levomilnacipran.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Levomilnacipran/06 - お - Side effects - Levomilnacipran.md,it,pending,2025-01-16,Side Effects
Antidepressants/Levomilnacipran/06 - お - Side effects - Levomilnacipran.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Levomilnacipran/07 -  - Use in special populations - Levomilnacipran.md,de,pending,2025-01-16,Use in special populations
Antidepressants/Levomilnacipran/07 -  - Use in special populations - Levomilnacipran.md,es,pending,2025-01-16,Use in special populations
Antidepressants/Levomilnacipran/07 -  - Use in special populations - Levomilnacipran.md,fr,pending,2025-01-16,Use in special populations
Antidepressants/Levomilnacipran/07 -  - Use in special populations - Levomilnacipran.md,it,pending,2025-01-16,Use in special populations
Antidepressants/Levomilnacipran/07 -  - Use in special populations - Levomilnacipran.md,pt,pending,2025-01-16,Use in special populations
Antidepressants/Levomilnacipran/08 -  Brand names - Levomilnacipran.md,de,pending,2025-01-16,Brand names
Antidepressants/Levomilnacipran/08 -  Brand names - Levomilnacipran.md,es,pending,2025-01-16,Brand names
Antidepressants/Levomilnacipran/08 -  Brand names - Levomilnacipran.md,fr,pending,2025-01-16,Brand names
Antidepressants/Levomilnacipran/08 -  Brand names - Levomilnacipran.md,it,pending,2025-01-16,Brand names
Antidepressants/Levomilnacipran/08 -  Brand names - Levomilnacipran.md,pt,pending,2025-01-16,Brand names
Antidepressants/Levomilnacipran/Commented/REV - 02 -  - Pharmacodynamics - Levomilnacipran 1.md,de,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Levomilnacipran/Commented/REV - 02 -  - Pharmacodynamics - Levomilnacipran 1.md,es,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Levomilnacipran/Commented/REV - 02 -  - Pharmacodynamics - Levomilnacipran 1.md,fr,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Levomilnacipran/Commented/REV - 02 -  - Pharmacodynamics - Levomilnacipran 1.md,it,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Levomilnacipran/Commented/REV - 02 -  - Pharmacodynamics - Levomilnacipran 1.md,pt,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Levomilnacipran/Commented/REV - 05 -  - Indications - Levomilnacipran.md,de,pending,2025-01-16,Indications
Antidepressants/Levomilnacipran/Commented/REV - 05 -  - Indications - Levomilnacipran.md,es,pending,2025-01-16,Indications
Antidepressants/Levomilnacipran/Commented/REV - 05 -  - Indications - Levomilnacipran.md,fr,pending,2025-01-16,Indications
Antidepressants/Levomilnacipran/Commented/REV - 05 -  - Indications - Levomilnacipran.md,it,pending,2025-01-16,Indications
Antidepressants/Levomilnacipran/Commented/REV - 05 -  - Indications - Levomilnacipran.md,pt,pending,2025-01-16,Indications
Antidepressants/Levomilnacipran/Commented/REV - 06 - お - Side effects - Levomilnacipran.md,de,pending,2025-01-16,Side Effects
Antidepressants/Levomilnacipran/Commented/REV - 06 - お - Side effects - Levomilnacipran.md,es,pending,2025-01-16,Side Effects
Antidepressants/Levomilnacipran/Commented/REV - 06 - お - Side effects - Levomilnacipran.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Levomilnacipran/Commented/REV - 06 - お - Side effects - Levomilnacipran.md,it,pending,2025-01-16,Side Effects
Antidepressants/Levomilnacipran/Commented/REV - 06 - お - Side effects - Levomilnacipran.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Levomilnacipran/Levomilnacipran.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Levomilnacipran/Levomilnacipran.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Levomilnacipran/Levomilnacipran.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Levomilnacipran/Levomilnacipran.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Levomilnacipran/Levomilnacipran.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Templates/01 -    - In a nutshell -  Template.md,de,pending,2025-01-16,In a nutshell
Antidepressants/Templates/01 -    - In a nutshell -  Template.md,es,pending,2025-01-16,In a nutshell
Antidepressants/Templates/01 -    - In a nutshell -  Template.md,fr,pending,2025-01-16,In a nutshell
Antidepressants/Templates/01 -    - In a nutshell -  Template.md,it,pending,2025-01-16,In a nutshell
Antidepressants/Templates/01 -    - In a nutshell -  Template.md,pt,pending,2025-01-16,In a nutshell
Antidepressants/Templates/02 -  - Pharmacodynamics - Documentation and Template.md,de,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Templates/02 -  - Pharmacodynamics - Documentation and Template.md,es,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Templates/02 -  - Pharmacodynamics - Documentation and Template.md,fr,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Templates/02 -  - Pharmacodynamics - Documentation and Template.md,it,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Templates/02 -  - Pharmacodynamics - Documentation and Template.md,pt,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Templates/03 -   - Pharmacokinetics - Documentation and Template.md,de,pending,2025-01-16,Pharmacokinetics
Antidepressants/Templates/03 -   - Pharmacokinetics - Documentation and Template.md,es,pending,2025-01-16,Pharmacokinetics
Antidepressants/Templates/03 -   - Pharmacokinetics - Documentation and Template.md,fr,pending,2025-01-16,Pharmacokinetics
Antidepressants/Templates/03 -   - Pharmacokinetics - Documentation and Template.md,it,pending,2025-01-16,Pharmacokinetics
Antidepressants/Templates/03 -   - Pharmacokinetics - Documentation and Template.md,pt,pending,2025-01-16,Pharmacokinetics
Antidepressants/Templates/04 -   - Dosage forms and strengths - Documentation and Template.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Templates/04 -   - Dosage forms and strengths - Documentation and Template.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Templates/04 -   - Dosage forms and strengths - Documentation and Template.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Templates/04 -   - Dosage forms and strengths - Documentation and Template.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Templates/04 -   - Dosage forms and strengths - Documentation and Template.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Templates/05 -  -  Indications - Documentation and Template.md,de,pending,2025-01-16,Indications
Antidepressants/Templates/05 -  -  Indications - Documentation and Template.md,es,pending,2025-01-16,Indications
Antidepressants/Templates/05 -  -  Indications - Documentation and Template.md,fr,pending,2025-01-16,Indications
Antidepressants/Templates/05 -  -  Indications - Documentation and Template.md,it,pending,2025-01-16,Indications
Antidepressants/Templates/05 -  -  Indications - Documentation and Template.md,pt,pending,2025-01-16,Indications
Antidepressants/Templates/06 - お - Side effects - Documentation and Template.md,de,pending,2025-01-16,Adverse effects
Antidepressants/Templates/06 - お - Side effects - Documentation and Template.md,es,pending,2025-01-16,Adverse effects
Antidepressants/Templates/06 - お - Side effects - Documentation and Template.md,fr,pending,2025-01-16,Adverse effects
Antidepressants/Templates/06 - お - Side effects - Documentation and Template.md,it,pending,2025-01-16,Adverse effects
Antidepressants/Templates/06 - お - Side effects - Documentation and Template.md,pt,pending,2025-01-16,Adverse effects
Antidepressants/Templates/07 -  - Use in special populations - Documentation and template.md,de,pending,2025-01-16,Use in special populations
Antidepressants/Templates/07 -  - Use in special populations - Documentation and template.md,es,pending,2025-01-16,Use in special populations
Antidepressants/Templates/07 -  - Use in special populations - Documentation and template.md,fr,pending,2025-01-16,Use in special populations
Antidepressants/Templates/07 -  - Use in special populations - Documentation and template.md,it,pending,2025-01-16,Use in special populations
Antidepressants/Templates/07 -  - Use in special populations - Documentation and template.md,pt,pending,2025-01-16,Use in special populations
Antidepressants/Templates/08 -  Brand names - Documentation and  Template.md,de,pending,2025-01-16,Brand names
Antidepressants/Templates/08 -  Brand names - Documentation and  Template.md,es,pending,2025-01-16,Brand names
Antidepressants/Templates/08 -  Brand names - Documentation and  Template.md,fr,pending,2025-01-16,Brand names
Antidepressants/Templates/08 -  Brand names - Documentation and  Template.md,it,pending,2025-01-16,Brand names
Antidepressants/Templates/08 -  Brand names - Documentation and  Template.md,pt,pending,2025-01-16,Brand names
Antidepressants/Templates/TEMPLATE.md,de,pending,2025-01-16,Indications
Antidepressants/Templates/TEMPLATE.md,es,pending,2025-01-16,Indications
Antidepressants/Templates/TEMPLATE.md,fr,pending,2025-01-16,Indications
Antidepressants/Templates/TEMPLATE.md,it,pending,2025-01-16,Indications
Antidepressants/Templates/TEMPLATE.md,pt,pending,2025-01-16,Indications
Antidepressants/Venlafaxine/01 - In a nutshell.md,de,pending,2025-01-16,In a nutshell
Antidepressants/Venlafaxine/01 - In a nutshell.md,es,pending,2025-01-16,In a nutshell
Antidepressants/Venlafaxine/01 - In a nutshell.md,fr,pending,2025-01-16,In a nutshell
Antidepressants/Venlafaxine/01 - In a nutshell.md,it,pending,2025-01-16,In a nutshell
Antidepressants/Venlafaxine/01 - In a nutshell.md,pt,pending,2025-01-16,In a nutshell
Antidepressants/Venlafaxine/02 -  - Pharmacodynamics - Venlafaxine.md,de,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Venlafaxine/02 -  - Pharmacodynamics - Venlafaxine.md,es,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Venlafaxine/02 -  - Pharmacodynamics - Venlafaxine.md,fr,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Venlafaxine/02 -  - Pharmacodynamics - Venlafaxine.md,it,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Venlafaxine/02 -  - Pharmacodynamics - Venlafaxine.md,pt,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Venlafaxine/03 -   - Pharmacokinetics - Venlafaxine.md,de,pending,2025-01-16,Pharmacokinetics
Antidepressants/Venlafaxine/03 -   - Pharmacokinetics - Venlafaxine.md,es,pending,2025-01-16,Pharmacokinetics
Antidepressants/Venlafaxine/03 -   - Pharmacokinetics - Venlafaxine.md,fr,pending,2025-01-16,Pharmacokinetics
Antidepressants/Venlafaxine/03 -   - Pharmacokinetics - Venlafaxine.md,it,pending,2025-01-16,Pharmacokinetics
Antidepressants/Venlafaxine/03 -   - Pharmacokinetics - Venlafaxine.md,pt,pending,2025-01-16,Pharmacokinetics
Antidepressants/Venlafaxine/04 -   - Dosage forms and strengths - Venlafaxine and desvenlafaxine.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Venlafaxine/04 -   - Dosage forms and strengths - Venlafaxine and desvenlafaxine.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Venlafaxine/04 -   - Dosage forms and strengths - Venlafaxine and desvenlafaxine.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Venlafaxine/04 -   - Dosage forms and strengths - Venlafaxine and desvenlafaxine.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Venlafaxine/04 -   - Dosage forms and strengths - Venlafaxine and desvenlafaxine.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Venlafaxine/05 -  - Indications - Venlafaxine.md,de,pending,2025-01-16,Indications
Antidepressants/Venlafaxine/05 -  - Indications - Venlafaxine.md,es,pending,2025-01-16,Indications
Antidepressants/Venlafaxine/05 -  - Indications - Venlafaxine.md,fr,pending,2025-01-16,Indications
Antidepressants/Venlafaxine/05 -  - Indications - Venlafaxine.md,it,pending,2025-01-16,Indications
Antidepressants/Venlafaxine/05 -  - Indications - Venlafaxine.md,pt,pending,2025-01-16,Indications
Antidepressants/Venlafaxine/06 - お - Side effects - Venlafaxine.md,de,pending,2025-01-16,Side Effects
Antidepressants/Venlafaxine/06 - お - Side effects - Venlafaxine.md,es,pending,2025-01-16,Side Effects
Antidepressants/Venlafaxine/06 - お - Side effects - Venlafaxine.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Venlafaxine/06 - お - Side effects - Venlafaxine.md,it,pending,2025-01-16,Side Effects
Antidepressants/Venlafaxine/06 - お - Side effects - Venlafaxine.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Venlafaxine/07 -  - Use in special populations - Venlafaxine.md,de,pending,2025-01-16,Use in special populations
Antidepressants/Venlafaxine/07 -  - Use in special populations - Venlafaxine.md,es,pending,2025-01-16,Use in special populations
Antidepressants/Venlafaxine/07 -  - Use in special populations - Venlafaxine.md,fr,pending,2025-01-16,Use in special populations
Antidepressants/Venlafaxine/07 -  - Use in special populations - Venlafaxine.md,it,pending,2025-01-16,Use in special populations
Antidepressants/Venlafaxine/07 -  - Use in special populations - Venlafaxine.md,pt,pending,2025-01-16,Use in special populations
Antidepressants/Venlafaxine/08 -  Brand names - Venlafaxine.md,de,pending,2025-01-16,Brand names
Antidepressants/Venlafaxine/08 -  Brand names - Venlafaxine.md,es,pending,2025-01-16,Brand names
Antidepressants/Venlafaxine/08 -  Brand names - Venlafaxine.md,fr,pending,2025-01-16,Brand names
Antidepressants/Venlafaxine/08 -  Brand names - Venlafaxine.md,it,pending,2025-01-16,Brand names
Antidepressants/Venlafaxine/08 -  Brand names - Venlafaxine.md,pt,pending,2025-01-16,Brand names
Antidepressants/Venlafaxine/BG004.md,de,pending,2025-01-16,In a nutshell
Antidepressants/Venlafaxine/BG004.md,es,pending,2025-01-16,In a nutshell
Antidepressants/Venlafaxine/BG004.md,fr,pending,2025-01-16,In a nutshell
Antidepressants/Venlafaxine/BG004.md,it,pending,2025-01-16,In a nutshell
Antidepressants/Venlafaxine/BG004.md,pt,pending,2025-01-16,In a nutshell
Antidepressants/Venlafaxine/Sources/Main Sources for Venlafaxine.md,de,pending,2025-01-16,
Antidepressants/Venlafaxine/Sources/Main Sources for Venlafaxine.md,es,pending,2025-01-16,
Antidepressants/Venlafaxine/Sources/Main Sources for Venlafaxine.md,fr,pending,2025-01-16,
Antidepressants/Venlafaxine/Sources/Main Sources for Venlafaxine.md,it,pending,2025-01-16,
Antidepressants/Venlafaxine/Sources/Main Sources for Venlafaxine.md,pt,pending,2025-01-16,
Antidepressants/Venlafaxine/Sources/Sources.md,de,pending,2025-01-16,
Antidepressants/Venlafaxine/Sources/Sources.md,es,pending,2025-01-16,
Antidepressants/Venlafaxine/Sources/Sources.md,fr,pending,2025-01-16,
Antidepressants/Venlafaxine/Sources/Sources.md,it,pending,2025-01-16,
Antidepressants/Venlafaxine/Sources/Sources.md,pt,pending,2025-01-16,
Antidepressants/Vortioxetine/01 -   - In a nutshell -  Vortioxetine.md,de,pending,2025-01-16,In a nutshell
Antidepressants/Vortioxetine/01 -   - In a nutshell -  Vortioxetine.md,es,pending,2025-01-16,In a nutshell
Antidepressants/Vortioxetine/01 -   - In a nutshell -  Vortioxetine.md,fr,pending,2025-01-16,In a nutshell
Antidepressants/Vortioxetine/01 -   - In a nutshell -  Vortioxetine.md,it,pending,2025-01-16,In a nutshell
Antidepressants/Vortioxetine/01 -   - In a nutshell -  Vortioxetine.md,pt,pending,2025-01-16,In a nutshell
Antidepressants/Vortioxetine/02 -  - Pharmacodynamics - Vortioxetine.md,de,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Vortioxetine/02 -  - Pharmacodynamics - Vortioxetine.md,es,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Vortioxetine/02 -  - Pharmacodynamics - Vortioxetine.md,fr,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Vortioxetine/02 -  - Pharmacodynamics - Vortioxetine.md,it,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Vortioxetine/02 -  - Pharmacodynamics - Vortioxetine.md,pt,pending,2025-01-16,Pharmacodynamics and mechanism of action
Antidepressants/Vortioxetine/03 -   - Pharmacokinetics - Vortioxetine.md,de,pending,2025-01-16,Pharmacokinetics
Antidepressants/Vortioxetine/03 -   - Pharmacokinetics - Vortioxetine.md,es,pending,2025-01-16,Pharmacokinetics
Antidepressants/Vortioxetine/03 -   - Pharmacokinetics - Vortioxetine.md,fr,pending,2025-01-16,Pharmacokinetics
Antidepressants/Vortioxetine/03 -   - Pharmacokinetics - Vortioxetine.md,it,pending,2025-01-16,Pharmacokinetics
Antidepressants/Vortioxetine/03 -   - Pharmacokinetics - Vortioxetine.md,pt,pending,2025-01-16,Pharmacokinetics
Antidepressants/Vortioxetine/04 -   - Dosage forms and strengths - Vortioxetine.md,de,pending,2025-01-16,Dosage forms
Antidepressants/Vortioxetine/04 -   - Dosage forms and strengths - Vortioxetine.md,es,pending,2025-01-16,Dosage forms
Antidepressants/Vortioxetine/04 -   - Dosage forms and strengths - Vortioxetine.md,fr,pending,2025-01-16,Dosage forms
Antidepressants/Vortioxetine/04 -   - Dosage forms and strengths - Vortioxetine.md,it,pending,2025-01-16,Dosage forms
Antidepressants/Vortioxetine/04 -   - Dosage forms and strengths - Vortioxetine.md,pt,pending,2025-01-16,Dosage forms
Antidepressants/Vortioxetine/05 -  - Indications - Vortioxetine.md,de,pending,2025-01-16,Indications
Antidepressants/Vortioxetine/05 -  - Indications - Vortioxetine.md,es,pending,2025-01-16,Indications
Antidepressants/Vortioxetine/05 -  - Indications - Vortioxetine.md,fr,pending,2025-01-16,Indications
Antidepressants/Vortioxetine/05 -  - Indications - Vortioxetine.md,it,pending,2025-01-16,Indications
Antidepressants/Vortioxetine/05 -  - Indications - Vortioxetine.md,pt,pending,2025-01-16,Indications
Antidepressants/Vortioxetine/06 - お - Side effects - Vortioxetine.md,de,pending,2025-01-16,Side Effects
Antidepressants/Vortioxetine/06 - お - Side effects - Vortioxetine.md,es,pending,2025-01-16,Side Effects
Antidepressants/Vortioxetine/06 - お - Side effects - Vortioxetine.md,fr,pending,2025-01-16,Side Effects
Antidepressants/Vortioxetine/06 - お - Side effects - Vortioxetine.md,it,pending,2025-01-16,Side Effects
Antidepressants/Vortioxetine/06 - お - Side effects - Vortioxetine.md,pt,pending,2025-01-16,Side Effects
Antidepressants/Vortioxetine/07 -  - Use in special populations - Vortioxetine.md,de,pending,2025-01-16,Use in special populations
Antidepressants/Vortioxetine/07 -  - Use in special populations - Vortioxetine.md,es,pending,2025-01-16,Use in special populations
Antidepressants/Vortioxetine/07 -  - Use in special populations - Vortioxetine.md,fr,pending,2025-01-16,Use in special populations
Antidepressants/Vortioxetine/07 -  - Use in special populations - Vortioxetine.md,it,pending,2025-01-16,Use in special populations
Antidepressants/Vortioxetine/07 -  - Use in special populations - Vortioxetine.md,pt,pending,2025-01-16,Use in special populations
Antidepressants/Vortioxetine/08 -  Brand names - Vortioxetine.md,de,pending,2025-01-16,Brand names
Antidepressants/Vortioxetine/08 -  Brand names - Vortioxetine.md,es,pending,2025-01-16,Brand names
Antidepressants/Vortioxetine/08 -  Brand names - Vortioxetine.md,fr,pending,2025-01-16,Brand names
Antidepressants/Vortioxetine/08 -  Brand names - Vortioxetine.md,it,pending,2025-01-16,Brand names
Antidepressants/Vortioxetine/08 -  Brand names - Vortioxetine.md,pt,pending,2025-01-16,Brand names
Articles/Antidepressants/Antidepressants and bleeding risk.md,de,pending,2025-01-16,
Articles/Antidepressants/Antidepressants and bleeding risk.md,es,pending,2025-01-16,
Articles/Antidepressants/Antidepressants and bleeding risk.md,fr,pending,2025-01-16,
Articles/Antidepressants/Antidepressants and bleeding risk.md,it,pending,2025-01-16,
Articles/Antidepressants/Antidepressants and bleeding risk.md,pt,pending,2025-01-16,
Articles/Antidepressants/Breastfeeding and Antidepressant Use.md,de,pending,2025-01-16,
Articles/Antidepressants/Breastfeeding and Antidepressant Use.md,es,pending,2025-01-16,
Articles/Antidepressants/Breastfeeding and Antidepressant Use.md,fr,pending,2025-01-16,
Articles/Antidepressants/Breastfeeding and Antidepressant Use.md,it,pending,2025-01-16,
Articles/Antidepressants/Breastfeeding and Antidepressant Use.md,pt,pending,2025-01-16,
Articles/Antidepressants/Comparison of SNRI.md,de,pending,2025-01-16,
Articles/Antidepressants/Comparison of SNRI.md,es,pending,2025-01-16,
Articles/Antidepressants/Comparison of SNRI.md,fr,pending,2025-01-16,
Articles/Antidepressants/Comparison of SNRI.md,it,pending,2025-01-16,
Articles/Antidepressants/Comparison of SNRI.md,pt,pending,2025-01-16,
Articles/Antidepressants/Effects of Desvenlafaxine on Blood Pressure.md,de,pending,2025-01-16,
Articles/Antidepressants/Effects of Desvenlafaxine on Blood Pressure.md,es,pending,2025-01-16,
Articles/Antidepressants/Effects of Desvenlafaxine on Blood Pressure.md,fr,pending,2025-01-16,
Articles/Antidepressants/Effects of Desvenlafaxine on Blood Pressure.md,it,pending,2025-01-16,
Articles/Antidepressants/Effects of Desvenlafaxine on Blood Pressure.md,pt,pending,2025-01-16,
Articles/Antidepressants/New antidepressants pharmacodynamic profile.md,de,pending,2025-01-16,
Articles/Antidepressants/New antidepressants pharmacodynamic profile.md,es,pending,2025-01-16,
Articles/Antidepressants/New antidepressants pharmacodynamic profile.md,fr,pending,2025-01-16,
Articles/Antidepressants/New antidepressants pharmacodynamic profile.md,it,pending,2025-01-16,
Articles/Antidepressants/New antidepressants pharmacodynamic profile.md,pt,pending,2025-01-16,
Articles/Antidepressants/Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder.md,de,pending,2025-01-16,
Articles/Antidepressants/Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder.md,es,pending,2025-01-16,
Articles/Antidepressants/Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder.md,fr,pending,2025-01-16,
Articles/Antidepressants/Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder.md,it,pending,2025-01-16,
Articles/Antidepressants/Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepresant-induced fractures.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepresant-induced fractures.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepresant-induced fractures.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepresant-induced fractures.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepresant-induced fractures.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant effects on Blood Pressure.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant effects on Blood Pressure.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant effects on Blood Pressure.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant effects on Blood Pressure.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant effects on Blood Pressure.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant-induced excessive sweating.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant-induced excessive sweating.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant-induced excessive sweating.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant-induced excessive sweating.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant-induced excessive sweating.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant-induced liver injury.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant-induced liver injury.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant-induced liver injury.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant-induced liver injury.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Antidepressant-induced liver injury.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Discontinuation - withdrawal syndrome.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Discontinuation - withdrawal syndrome.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Discontinuation - withdrawal syndrome.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Discontinuation - withdrawal syndrome.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Discontinuation - withdrawal syndrome.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Dose-related hypertension.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Dose-related hypertension.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Dose-related hypertension.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Dose-related hypertension.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Dose-related hypertension.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Gastrointestinal Side Effects.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Gastrointestinal Side Effects.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Gastrointestinal Side Effects.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Gastrointestinal Side Effects.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Gastrointestinal Side Effects.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Hyponatremia.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Hyponatremia.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Hyponatremia.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Hyponatremia.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Hyponatremia.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Ocular effects of antidepressants.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Ocular effects of antidepressants.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Ocular effects of antidepressants.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Ocular effects of antidepressants.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Ocular effects of antidepressants.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Risk factors for hyponatremia.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Risk factors for hyponatremia.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Risk factors for hyponatremia.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Risk factors for hyponatremia.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Risk factors for hyponatremia.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Serotonin Syndrome.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Serotonin Syndrome.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Serotonin Syndrome.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Serotonin Syndrome.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Serotonin Syndrome.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Sexual dysfunction.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Sexual dysfunction.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Sexual dysfunction.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Sexual dysfunction.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Sexual dysfunction.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Tool for evaluation of the risk of antidepressant discontinuation.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Tool for evaluation of the risk of antidepressant discontinuation.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Tool for evaluation of the risk of antidepressant discontinuation.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Tool for evaluation of the risk of antidepressant discontinuation.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Tool for evaluation of the risk of antidepressant discontinuation.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Treatment emergent affective switch.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Treatment emergent affective switch.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Treatment emergent affective switch.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Treatment emergent affective switch.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Treatment emergent affective switch.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Vortioxetine reduced bleeding risk?.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Vortioxetine reduced bleeding risk?.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Vortioxetine reduced bleeding risk?.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Vortioxetine reduced bleeding risk?.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Vortioxetine reduced bleeding risk?.md,pt,pending,2025-01-16,
Articles/Antidepressants/Side effects/Weight Gain and Metabolic Side Effects of Antidepressants.md,de,pending,2025-01-16,
Articles/Antidepressants/Side effects/Weight Gain and Metabolic Side Effects of Antidepressants.md,es,pending,2025-01-16,
Articles/Antidepressants/Side effects/Weight Gain and Metabolic Side Effects of Antidepressants.md,fr,pending,2025-01-16,
Articles/Antidepressants/Side effects/Weight Gain and Metabolic Side Effects of Antidepressants.md,it,pending,2025-01-16,
Articles/Antidepressants/Side effects/Weight Gain and Metabolic Side Effects of Antidepressants.md,pt,pending,2025-01-16,
Articles/Antidepressants/Stopping antidepressants.md,de,pending,2025-01-16,
Articles/Antidepressants/Stopping antidepressants.md,es,pending,2025-01-16,
Articles/Antidepressants/Stopping antidepressants.md,fr,pending,2025-01-16,
Articles/Antidepressants/Stopping antidepressants.md,it,pending,2025-01-16,
Articles/Antidepressants/Stopping antidepressants.md,pt,pending,2025-01-16,
Articles/Antidepressants/Switching antidepressants.md,de,pending,2025-01-16,
Articles/Antidepressants/Switching antidepressants.md,es,pending,2025-01-16,
Articles/Antidepressants/Switching antidepressants.md,fr,pending,2025-01-16,
Articles/Antidepressants/Switching antidepressants.md,it,pending,2025-01-16,
Articles/Antidepressants/Switching antidepressants.md,pt,pending,2025-01-16,
Articles/Antidepressants/Vortioxetine and TESD.md,de,pending,2025-01-16,
Articles/Antidepressants/Vortioxetine and TESD.md,es,pending,2025-01-16,
Articles/Antidepressants/Vortioxetine and TESD.md,fr,pending,2025-01-16,
Articles/Antidepressants/Vortioxetine and TESD.md,it,pending,2025-01-16,
Articles/Antidepressants/Vortioxetine and TESD.md,pt,pending,2025-01-16,
Articles/Ideas.md,de,pending,2025-01-16,
Articles/Ideas.md,es,pending,2025-01-16,
Articles/Ideas.md,fr,pending,2025-01-16,
Articles/Ideas.md,it,pending,2025-01-16,
Articles/Ideas.md,pt,pending,2025-01-16,
